main-logomain-logomain-logomain-logo
  • Home
  • About Us
    • About Us
    • Doctors
    • History
    • Reviews
  • Cancer Care
    • Cancers & Treatments
    • Our Patients’ Stories
    • Patient Review
  • Clinical Trials
  • Contact us
    • Phone/Address/Fax
    • Become A Patient
    • Patient Portal
    • Make A Payment
    • Schedule Your Appointment Online
    • Prescription Refills

157 E 32nd St.
New York, NY
212-689-6791

UArizona researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer October, 2022

Published by Andy LoCascio at April 25, 2021
Categories
  • Latest News
Tags

 

Andy LoCascio
Andy LoCascio

Related posts

March 24, 2020

How MHOA Is Protecting Our Patients and Staff from COVID-19


Read more
January 25, 2020

Scientists have discovered more about the mysterious role of epigenetics, the study of how genes change, in controlling the way cancers develop. October, 2022


Read more
April 25, 2021

Exploring Emerging IO Combinations in Hepatocellular Carcinoma


Read more

Legal Disclaimer

The Information contained or referenced in the Manhattan Hematology Oncology Associates (MHOA) website is for educational and communications purposes only.
The site does not provide medical advice and should not be used as a substitute for professional help. The information is intended to support, not replace, the patient-physician
relationship and the content is provided only as an educational resource. The MHOA website offers hyperlinks to other organizations and web pages and MHOA is not responsible for
information or advice contained in those sites.